Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies.
10.1186/s13045-020-00924-z He et al. J Hematol Oncol
He Y, Khan S, Huo Z, Lv D, Zhang X, Liu X, Yuan Y, Hromas R, Xu M, Zheng G, Zhou D
Study details